Page last updated: 2024-12-06

nitrosocarbaryl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nitrosocarbaryl: combination of food additive sodium nitrite with carbaryl (SEVIN) results in formation of acid solution of potent mutagen; RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nitrosocarbaryl : A nitroso compound that is carbaryl in which the amino hydrogen is substituted by a nitroso group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID23493
CHEBI ID189529
MeSH IDM0052682

Synonyms (33)

Synonym
nitrosocarbaryl
carbamic acid, methylnitroso-, 1-naphthalenyl ester
1-naphthyl-n-methyl-n-nitrosocarbamate
1-naphthalenyl methylnitrosocarbamate
1-naphthyl methylnitrosocarbamate
ccris 1217
methyl-nitrosocarbamic acid 1-naphthyl ester
1-naphthyl n-methyl-n-nitrosocarbamate
denapon, nitrosated [japanese]
carbamic acid, methylnitroso-, 1-naphthyl ester
n-nitroso-1-naphthyl-n-methylcarbamate
1-naphthyl methylnitrosocarbonate
carbamic acid, n-methyl-n-nitroso-, 1-naphthyl ester
brn 1980650
nitroso-nac
n-nitrosocarbaryl
n-methyl-n-nitrosocarbamic acid 1-naphthyl ester
CHEBI:189529
denapon, nitrosated
1-naphthalenyl n-methyl-n-nitrosocarbamate
7090-25-7
naphthalen-1-yl methyl(nitroso)carbamate
carbamic acid, methylnitroso-, naphthalenyl ester
64158-97-0
naphthalenyl methylnitrosocarbamate
c0719mrf0l ,
unii-c0719mrf0l
carbamic acid, n-methyl-n-nitroso-, 1-naphthalenyl ester
1-naphthyl 1-methyl-2-oxohydrazinecarboxylate #
FFSXTYIBUNXZMF-UHFFFAOYSA-N
DTXSID30876699
n-me-n-nitroso-1-naphthylcarbamat
Q27275003

Research Excerpts

Overview

N-Nitrosocarbaryl is an inhibitor of the two investigated microsomal monooxygenases at doses of 25 and 50 mg/kg when administered on 4 consecutive days.

ExcerptReferenceRelevance
"N-Nitrosocarbaryl is an inhibitor of the two investigated microsomal monooxygenases at doses of 25 and 50 mg/kg when administered on 4 consecutive days."( Inhibition of two rat hepatic microsomal drug-metabolizing enzymes by a carcinogenic N-nitrosated pesticide: N-nitrosocarbaryl.
Beraud, M; Derache, R; Gaillard, S, 1980
)
1.03

Dosage Studied

ExcerptRelevanceReference
" Dose-response relationships were obtained for NMU and NC as well as for BaP."( Local application to mouse skin as a carcinogen specific test system for non-volatile nitroso compounds.
Brune, H; Deutsch-Wenzel, RP; Grimmer, G; Misfeld, J, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
naphthalenesAny benzenoid aromatic compound having a skeleton composed of two ortho-fused benzene rings.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
nitroso compoundCompounds having the nitroso group, -NO, attached to carbon, or to another element, most commonly nitrogen or oxygen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]